Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

Sarici, Ahmet; Bicim, Soykan; Erkurt, Mehmet Ali; Berber, Ilhami; Kaya, Emin; Kuku, Irfan; Ozgul, Mustafa

ABAKÜS Ana Sayfası
→
Dergiler
→
İnönü Üniversitesi Tıp Fakültesi Dergisi
→
(2021)
→
Sayı: 12 (Aralık)
→
Öğe Göster

dc.contributor.author	Sarici, Ahmet
dc.contributor.author	Bicim, Soykan
dc.contributor.author	Erkurt, Mehmet Ali
dc.contributor.author	Berber, Ilhami
dc.contributor.author	Kaya, Emin
dc.contributor.author	Kuku, Irfan
dc.contributor.author	Ozgul, Mustafa
dc.date.accessioned	2022-03-15T10:46:31Z
dc.date.available	2022-03-15T10:46:31Z
dc.date.issued	2021
dc.identifier.citation	Sarici, A., Bicim, S., Erkurt, M. A., Berber, I., Kaya, E., Kuku, I., & Ozgul, M. (2021). Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma. Annals of Medical Research	en_US
dc.identifier.uri	http://hdl.handle.net/11616/55648
dc.description.abstract	The Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus detected in the Wuhan Province of the People's Republic of China caused a pandemic in a very short time all over the world. Convalescent plasma (CP) therapy is a passive antibody therapy that has been shown to be effective in epidemic periods. CP therapy has been of interest in the treatment of infection with no vaccine or specific treatment, such as the Sars-CoV-2 infection that causes COVID-19. We aimed to report our CP experience in Sars-Cov-2 infection in our relapsed / refractory Multiple myeloma (MM) patient.	en_US
dc.language.iso	eng	en_US
dc.rights	info:eu-repo/semantics/openAccess	en_US
dc.title	Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma	en_US
dc.type	article	en_US
dc.relation.journal	Annals of Medical Research	en_US
dc.contributor.department	İnönü Üniversitesi	en_US